APA (7th ed.) Citation

Kumar, A., Jerzak, K. J., Gelmon, K. A., Boileau, J., Bouganim, N., Brezden-Masley, C., . . . Manna, M. (2026). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update). Current Oncology, 33(4), 200. https://doi.org/10.3390/curroncol33040200

Chicago Style (17th ed.) Citation

Kumar, Aalok, et al. "Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)." Current Oncology 33, no. 4 (2026): 200. https://doi.org/10.3390/curroncol33040200.

MLA (9th ed.) Citation

Kumar, Aalok, et al. "Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)." Current Oncology, vol. 33, no. 4, 2026, p. 200, https://doi.org/10.3390/curroncol33040200.